Johnson & Johnson made several key financial announcements this morning about its third-quarter performance in 2018:
- Company sales in the third quarter totaled $20.3 billion—up 3.6% over last quarter
- The adjusted diluted earnings per share was $2.05, reflecting a 7.9% increase
- The company registered growth in its Consumer and Pharmaceutical sectors around the globe. Its Pharmaceutical business, for example, reported a worldwide sales increase of 6.7% in the third quarter
Check out this infographic for more details about the company's third-quarter 2018 results, and read a message from, Chairman and Chief Executive Officer, Johnson & Johnson.